![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
 | Up a level |
Group by: Item Type | No Grouping
Number of items: 1.
Syamprasad, NP and Jain, S and Rajdev, B and Panda, SR and Gangasani, JK and Challa, VS and Vaidya, JR and Kundu, GC and Naidu, VGM (2023) AKR1B1 inhibition using NARI-29-an Epalrestat analogue- alleviates Doxorubicin-induced cardiotoxicity via modulating Calcium/CaMKII/MuRF-1 axis. Chemico-Biological Interactions (381).
|
IR@NCCS is powered by EPrints 3 and Maintained by CSIR-URDIP, Pune
IR@NCCS supports OAI 2.0 with a base URL http://nccs.sciencecentral.in/cgi/oai2
|